| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |